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WE have been interested in the induction of whole 
organ graft acceptance using a brief course of 
intramuscular FK 506 in the early postoperative periodKfK~ 
We use the term graft acceptance advisedly. since the 
long-term surviving animals we describe in this paper are 
not tolerant in the classical sense. 
EXPERIMENTAL MODELS 
Our experimental models. using Lewis rat recipients. were 
(I) heterotopic heart transplantation according to Ono and 
Lindsey.3 (2) orthotopic liver transplantation with a mod-
ification of Kamada and Calne's technique. 4 and (3) mul-
tivisceral transplantation by our own techniques.-' 
LIVER TRANSPLANTATION 
In some respects. the orthotopic liver transplantation was 
the most interesting preparation. The key observations. 
culled from more complete studies to be reported 
elsewhere.b •7 are summarized in Fig I. The ACI to Lewis 
liver transplantation is across a major histocompatibility 
barrier. Yet. it is possible with a 3-day course of intramus-
cular FK 506. started on the day of operation or at any time 
up to the fourth postoperative day. to induce permanent 
acceptance of the majority of the liver grafts. 
What are the changes in the Lewis recipient that permit 
this acceptance of ACI livers? The recipients. by 100 and 
300 days. were not immunodepressed because they could 
vigorously reject skin grafts. not only from third-party 
(Brown Norway, donors. but also from ACl rats. Thus. 
acceptance of the liver grafts did not endow privilege to 
other tissues from the original donor strain. Whether 
another ACI liver would be accepted has not been deter-
mined. This will require removal of a chronically accepted 
liver and retransplantation with a second ACI liver. 
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Fig 1. Liver transplantation. 
It has been shown that the lymphocyte subset popula-
tion does not differ from normal samples in these animals. 7 
The immunologic status of· the recipients has been as-
sessed in other ways.b.7 including one-way mixed lympho-
cyte reactions using mesenteric lymph node cells obtained 
from Lewis recipients who were bearing long-surviving 
liver grafts. Irradiated spleen cells from ACI or third-party 
Brown Norway rats were added. The Lewis lymphocytes 
retained a normal to weakened ability to respond to the 
ACI alloantigens. The potency of the reaction to the 
Brown Norway splenocytes was normal. In the tissue 
culture experiments. suppressor cells in the recipient Iym· 
phoid tissue could not be demonstrated. 7 Similarly. failure 
to affect rejection in adoptive transfer experiments. using 
the spleen of long-surviving liver recipients as the cell 
source. suggested that splenic suppressor cells either were 
unimportant or absent as a factor in this form of liver graft 
acceptance.7 
It was noteworthy that the transplanted animals re-
mained capable of mounting a graft-versus-host (GVH) 
reaction against ACI donor histocompatibility antigens in 
vivo. This was demonstrated with the popliteal lymph· 
node assay technique.7 
HEART TRANSPLANTATION 
It was more difficult with hearts to induce graft accep-
tance. and the exact details of dose timing were more 
critical (Fig 2)." The best time to give a 1.28 mg/kg/d 
intramuscular course was on postoperative days 4. 5. and 
6. A further difference. compared with the liver. was that 
graft acceptance usually was not permanent (Fig 2). Even 
in the best groups. the hearts were gradually rejected. long 
after transplantation. Nevertheless. a second ACI heart 
transplanted to the neck 4 weeks after the first (intraab-
domina!) one had prolongation of its survival. This was not 
true with third-party Brown Norway hearts. indicating that 
the temporary heart graft acceptance was strain-specific. 7 
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Fig 2. Heart transplantation. 
However. survival was not enhanced for skin grafts from 
either ACI or Brown Norway donors at 4 weeks after 
primary heart transplantation. 7 
The total number of lymphocytes in the heart grafts was 
reduced. but the prolongation of heart grafts could not be 
explained by a change in the lymphocyte subset propor-
tions. which were unchanged from normaL!> Failure of 
splenectomy to influence the outcome. and failure to 
demonstrate adoptive transfers with the spleens of chronic 
surviving heart recipients. were construed as evidence 
against the existence of a suppressor cell component to 
this form of graft acceptance. 
MUL TIVISCERAL AND INTESTINAL TRANSPLANTATION 
Consistent chronic survival after multi visceral transplan-
tation has not been achieved in animals. In a previous 
study in unmodified Lewis recipients of Brown Norway 
multivisceral grafts.s the small bowel was found to be 
selectively vulnerable to rejection. which killed all animals 
between 10 to \3 days (Table I). With 14 intramuscular 
doses of 0.32 or 0.64 mg/kg FK 506. we now have six 
animals living for 24 to 72 days (Table I), These surviving 
rats are gaining weight and have not yet exhibited evidence 
of GVH disease. These results. as well as other reports at 
75 
Table 1. Effect of FK 506 on MuHlvlsceral Transplantation 
Treatment 
Donor Recipient With FK 506 N Survival 
LEW LEW 6 >100 x 5. 7,' 72.' 81' 
BN LEW 5 
BN LEW 0.32 mg/kg: 14 d 3 
BN LEW 0.64 mg/kg; 14 d 3 
AbbreVIations: LEW. Lewis: BN. Brown Norway. 
• Technical problem 
t Killed in healthy condrtlOn. 
10.10.10. 10, 13 
>32. >25. >24 
>72. >67. >66 
this meeting on intestinal transplantation. have encouraged 
us to believe that FK 506 may permit successful transplan-
tation of the previously forbidden hollow gastrointestinal 
viscera. 
DISCUSSION 
With short courses of intramuscular FK 506. long-term 
heart. liver. multi visceral. and small bowel homograti 
acceptance can be induced in rats. The acceptance is 
long-term for liver. partial and variable for hearts. and as 
yet undetermined for intestinal and multivisceral gratis. 
Those recipients bearing functioning allografts do not have 
classical tolerance. Although the mechanism( s) of this type 
of organ acceptance have not been fully determined. the 
practical clinical importance of such acceptance may be 
considerable. 
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